Everissa

Everissa is a combined oral contraceptive containing drospirenone and ethinylestradiol. It is used for birth control and may help manage acne. This medication is manufactured by Gedeon Richter Plc. and is suitable for oral use.

Everissa is primarily used as a contraceptive to prevent pregnancy. It works by inhibiting ovulation and altering the cervical mucus to prevent sperm from reaching the egg. Additionally, it may be prescribed to manage acne in women who also require contraception. The active ingredients, drospirenone and ethinylestradiol, contribute to its effectiveness in these areas.

Common effects of Everissa may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users may experience breast tenderness, headaches, or nausea. These effects vary among individuals and typically subside as the body adjusts to the medication.

Everissa should be used with caution in individuals with a history of blood clots, liver disease, or high blood pressure. It is important to discuss your medical history with a healthcare provider before starting this medication. Regular monitoring may be recommended for certain conditions.

Everissa may interact with other medications, including certain antibiotics, anticonvulsants, and HIV medications. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.